Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,238 | -43,319 | -21,655 | -5,417 | -1,968 |
| Depreciation Amortization | 1,765 | 2,618 | 1,401 | 259 | 94 |
| Accounts receivable | -2,842 | -8,810 | -7,940 | N/A | 0 |
| Accounts payable and accrued liabilities | 3,161 | 1,356 | 4,031 | N/A | 707 |
| Other Working Capital | -2,435 | -6,071 | -1,854 | 3,179 | 756 |
| Other Operating Activity | -2,537 | 31,636 | 9,679 | 899 | -221 |
| Operating Cash Flow | $-13,126 | $-22,590 | $-16,338 | $-1,079 | $-632 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -194 | -99 | N/A | N/A | N/A |
| Net Acquisitions | N/A | -5,137 | 2,761 | N/A | N/A |
| Investing Cash Flow | $-194 | $-5,236 | $2,761 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 17,898 | N/A | N/A | N/A |
| Debt Issued | 29,337 | 28,077 | 28,077 | 625 | 250 |
| Debt Repayment | -1,814 | -845 | -845 | N/A | N/A |
| Common Stock Issued | N/A | 206 | 85 | N/A | N/A |
| Financing Cash Flow | $27,523 | $45,336 | $27,317 | $625 | $250 |
| Beginning Cash Position | 18,023 | 513 | 513 | 513 | 513 |
| End Cash Position | 32,226 | 18,023 | 14,253 | 59 | 131 |
| Net Cash Flow | $14,203 | $17,510 | $13,740 | $-454 | $-382 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,126 | -22,590 | -16,338 | -1,079 | -632 |
| Capital Expenditure | -194 | -99 | N/A | N/A | 0 |
| Free Cash Flow | -13,320 | -22,689 | -16,338 | -1,079 | -632 |